Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Predicting outcomes in RCC using cell cycle progression score

Jeff Tosoian, MD, MPH, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, discusses the use of cell cycle progression (CCP) score to risk stratify prostate cancer. The CCP score could also predict the likelihood of cancer recurrence in renal cell cancer (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.